HLY78 |
GSK3β/Sirt1/PGC-1α pathway |
Antioxidation |
ICH model (induced via autologous blood injection) |
Jin et al. [148] |
Resveratrol |
NF-κB/p65 deacetylating |
Anti-neuroinflammation |
ICH model (intracranial injection of type IV collagenase) |
Deng et al. [120] |
Fucoxanthin (Fx) |
Activating Sirt1 and further deacetylating FOXO and p53 |
Antioxidation |
SAH model (prechiasmatic cistern injection models) |
Zhang et al. [150] |
Salvianolic acid B (SalB) |
Activating SIRT1 and Nrf2 signaling pathway |
Antioxidation |
SAH model (single blood injection) |
Zhang et al. [153] |
Melatonin (Mel) |
Activating MR/Sirt1/NF-κB pathway |
Anti-neuroinflammation and antioxidation |
SAH model (endovascular perforation model) |
Zhao et al. [158] |
Berberine |
Activating sirtuin 1 and suppressing HMGB1/NF-κB pathway |
Anti-neuroinflammation |
SAH model (prechiasmatic cistern injection models) |
Zhang et al. [161] |
Oleanolic acid |
SIRT1-mediated HMGB1 deacetylation |
Anti-neuroinflammation |
SAH model (endovascular perforation model) |
Han et al. [162] |
Carnosic acid (CA) |
Activating SIRT1/p66shc pathway |
Antioxidation |
SAH model (endovascular perforation model) |
Teng et al. [164] |
Wogonoside |
Activating SIRT1 and further deregulating p53 |
Anti-neuroinflammation |
SAH model (endovascular perforation model) |
Cheng et al. [166] |